Despite advances in schizophrenia treatment, symptom relapses and rehospitalizations impede recovery for many people and are a principal driver of the high cost of care. Technology-delivered or enhanced treatment may be a cost-effective way to provide flexible, personalized evidence-based treatments directly to people in their homes and communities.
Our team is involved in the development of a novel, technology-based approach to prevent relapse after a hospitalization for psychosis, the Health Technology Program (HTP). HTP provides in-person relapse prevention planning that directs use of tailored, technology-based treatment based on CBT for psychosis- and family psychoeducation for schizophrenia, as well as prescriber decision support through a clinician-facing, web-based program that solicits information from clients at every visit. Technology-based treatments are delivered through smartphones and computers. HTP is currently being evaluated in people with schizophrenia who were recently discharged from a psychiatric hospitalization, a period when they are at particularly high-risk for relapses.
Our group is leading the mHealth element of this multi-site implementation project in several states including:
Funded by: Center for Medicare & Medicaid Innovation (CMMI)